Add this topic to your myFT Digest for news straight to your inbox
ValueAct will get confidential data on the US bank without taking a board seat
President to stand down as investors make breakthrough in two-year campaign
Share sale may return star fund manager to the ascendant
Obvious move would be to ditch underperforming cameras unit and focus on medical devices
Planned changes to corporate governance requirements embolden foreign funds
Bank’s critics seize on activist’s arrival despite friendly tone
Activist investor says shares in US bank lag behind peers
Hedge fund is now third-largest shareholder of theme park operator hit by downgrade
AMG chief Sean Healey looks ahead to “incredibly exciting” next ten years
Hedge fund’s sometimes belligerent statements mask a careful and dogged strategy
Activist hedge fund promotes long-time partner Mason Morfit
Activist hedge fund discloses 2% holding in investment bank
ValueAct’s investment needs a leg-up from the Federal Reserve
BlackRock, Pimco and 12 other investors’ investments in bonds from Novo Banco were wiped out
Hedge fund vows to fight government over its stakebuilding in Halliburton and Baker Hughes
Pearson as chief executive brought a consultant’s clinical eye to the pharma industry
Agreement with US activist makes seat conditional on shareholding
UK engineer to back application after activist investor reassures on good intentions
Departures are part of broader efforts to cut costs at group reeling from five profit warnings
Activists sounded out over taking stake in world’s largest healthcare company
International Edition